Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.1300.799.491
Address
Suite 8, Level 3 299 Toorak Road South Yarra, Victoria (VIC) 3141
Description
Vitura Health Ltd. engages in the sale and distribution of medicinal cannabis products and the operation of medicinal cannabis clinic businesses. It operates through the following segments: Sales and Distribution; and Clinics and Services. The Sales and Distribution segment involves in the sale and distribution of medical products including medicinal cannabis, psychedelic drugs and smoking cessation products. The Clinics and Services segment involves in the the operation of medicinal cannabis clinics and the provision of related services. The company was founded on September 27, 2018 and is headquartered in South Yarra, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.06 - 0.14
Trade Value (12mth)
AU$9,421.00
1 week
-2.78%
1 month
-4.11%
YTD
-14.63%
1 year
-24.73%
All time high
1.04
EPS 3 yr Growth
77.10%
EBITDA Margin
5.30%
Operating Cashflow
$7m
Free Cash Flow Return
16.60%
ROIC
8.40%
Interest Coverage
7.50
Quick Ratio
1.10
Shares on Issue (Fully Dilluted)
577m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
04-Sep-23
Next Dividend Pay Date (est.)
28-Sep-23
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
23 April 25 |
Change in substantial holding
×
Change in substantial holding |
22 April 25 |
Notification of cessation of securities - VIT
×
Notification of cessation of securities - VIT |
10 April 25 |
Response to ASX Letter about Director Trading
×
Response to ASX Letter about Director Trading |
07 March 25 |
S&P DJI Announces March 2025 Quarterly Rebalance
×
S&P DJI Announces March 2025 Quarterly Rebalance |
04 March 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
28 February 25 |
Investor webinar and presentation
×
Investor webinar and presentation |
28 February 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 February 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
26 February 25 |
Appendix 4D
×
Appendix 4D |
26 February 25 |
2025 Half-Year Financial Report
×
2025 Half-Year Financial Report |
26 February 25 |
H1 FY2025 financial results
×
H1 FY2025 financial results |
26 February 25 |
Vitura completes acquisition of Canview platform
×
Vitura completes acquisition of Canview platform |
26 February 25 |
Application for quotation of securities - VIT
×
Application for quotation of securities - VIT |
26 February 25 |
Cleansing Notice
×
Cleansing Notice |
20 February 25 |
Vitura completes acquisition of Candor Medical
×
Vitura completes acquisition of Candor Medical |
19 February 25 |
Update - Proposed issue of securities - VIT
×
Update - Proposed issue of securities - VIT |
17 February 25 |
Becoming a substantial holder - updated
×
Becoming a substantial holder - updated |
14 February 25 |
Change in substantial holding
×
Change in substantial holding |
13 February 25 |
Application for quotation of securities - VIT
×
Application for quotation of securities - VIT |
13 February 25 |
Section 708A Cleansing Notice
×
Section 708A Cleansing Notice |
13 February 25 |
Notice of Initial Substantial Holder - AFO
×
Notice of Initial Substantial Holder - AFO |
13 February 25 |
Change of Substantial Holder - E Jansen
×
Change of Substantial Holder - E Jansen |
13 February 25 |
Change of Substantial Holder - M Jansen
×
Change of Substantial Holder - M Jansen |
13 February 25 |
Change of Substantial Holder - G Headley
×
Change of Substantial Holder - G Headley |
12 February 25 |
Vitura raises $5.1 million from Charlie Shahin AO
×
Vitura raises $5.1 million from Charlie Shahin AO |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.